Bandingkan Harga & Kinerja Intikeramik Alamasri Industri Tbk. (IKAI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Intikeramik Alamasri Industri Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Intikeramik Alamasri Industri Tbk. diperdagangkan di Rp20 (kapitalisasi pasar 252,81 M, volume 24 jam 32,86 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp246 (kapitalisasi pasar 167,37 M, volume 24 jam 71 rb). Perbedaan utamanya: Intikeramik Alamasri Industri Tbk. lebih besar dari sisi kapitalisasi pasar, dan Intikeramik Alamasri Industri Tbk. lebih aktif diperdagangkan (32,86 jt vs 71 rb). Mana yang lebih baik tergantung tujuan investasimu.
| IKAI | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 252,81 M | 167,37 M |
Volume | 32,86 jt | 71 rb |
Lot | 328,61 rb | 710 |
Perputaran | 657,21 jt | 17,51 jt |
Harga Rata-rata | 20 | 246,63 |
Nilai Transaksi | 657,21 jt | 17,51 jt |
Harga Ekuilibrium Indikatif | 20 | 246 |
Volume Ekuilibrium Indikatif | 2,26 rb | 1 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Intikeramik Alamasri Industri Tbk.
PT Intikeramik Alamasri Industri Tbk (the Company) was established under the name PT Intikeramik Alamasri Indah based on notarial deed No. 38 dated June 26, 1991 and was amended with notarial deed No. 16 dated December 14, 1991, both made by Raden Muhammad Hendarmawan, S.H., Notary in Jakarta. PT Intikeramik Alamasri Industri Tbk is the pioneer of large-scale porcelain tile manufacture in Indonesia and one of the largest producers in the Asia Pacific region. Porcelain tiles are superior in term of strength, durability and design versatility to natural stone as well as other synthetics such as glazed tiles. Porcelain is attractive and affordable for use in both commercial and residential developments and has strong following among international architects and interior designers. Intikeramik is seeking to build a leading profile in markets across Europe, America and Asia drawing upon its reputation for consistency, advanced manufacturing technology, a low cost base and substantial available capacity. The company has consolidation production capacity 6,600,000 m2 /year.
Selengkapnya di halaman IKAI →Tentang Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →
